PSCH vs. CNCR

Last updated Jun 24, 2026

PSCH (Invesco S&P SmallCap Health Care ETF) and CNCR (Loncar Cancer Immunotherapy ETF) are both Health & Biotech Equities funds - PSCH tracks the S&P SmallCap 600 Health Care Index while CNCR tracks the Loncar Cancer Immunotherapy Index. Both are passively managed. PSCH charges 0.29%/yr vs 0.79%/yr for CNCR.

Performance

PSCH vs. CNCR - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Invesco S&P SmallCap Health Care ETF (PSCH) and Loncar Cancer Immunotherapy ETF (CNCR). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

PSCH

• 1D: 1.22%
• 1M: 10.05%
• YTD: 11.73%
• 6M: 7.03%
• 1Y: 24.00%
• 3Y*: 4.19%
• 5Y*: -5.17%
• 10Y*: 8.18%

CNCR

• 1D: 0.00%
• 1M: 0.00%
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

PSCH vs. CNCR - Yearly Performance Comparison

	2026 (YTD)
PSCH Invesco S&P SmallCap Health Care ETF	15.28%
CNCR Loncar Cancer Immunotherapy ETF	0.00%

PSCH vs. CNCR - Sectors Allocation Comparison

Sectors	PSCH	CNCR
Healthcare	97.5%	96.6%
Technology	1.5%	-
Financial Services	0.9%	3.3%
Industrials	0.7%	-
Basic Materials	-	-
Communication Services	-	-
Consumer Cyclical	-	-
Consumer Defensive	-	-
Energy	-	-
Real Estate	-	-
Utilities	-	-

Return for Risk

PSCH vs. CNCR — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

PSCH

PSCH Risk / Return Rank: 34
PSCH Sharpe Ratio Rank: 34
PSCH Sortino Ratio Rank: 36
PSCH Omega Ratio Rank: 33
PSCH Calmar Ratio Rank: 33
PSCH Martin Ratio Rank: 34

CNCR

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

PSCH vs. CNCR - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Invesco S&P SmallCap Health Care ETF (PSCH) and Loncar Cancer Immunotherapy ETF (CNCR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	PSCH	CNCR	Difference
Sharpe ratio: Return per unit of total volatility	1.18	—	—
Sortino ratio: Return per unit of downside risk	1.78	—	—
Omega ratio: Gain probability vs. loss probability	1.21	—	—
Calmar ratio: Return relative to maximum drawdown	1.57	—	—
Martin ratio: Return relative to average drawdown	4.73	—	—

Drawdowns

PSCH vs. CNCR - Drawdown Comparison

The maximum PSCH drawdown since its inception was -46.32%, which is greater than CNCR's maximum drawdown of 0.00%. Use the drawdown chart below to compare losses from any high point for PSCH and CNCR.

Drawdown Indicators

	PSCH	CNCR	Difference
Max Drawdown Largest peak-to-trough decline	-46.32%	0.00%	-46.32%
Max Drawdown (1Y) Largest decline over 1 year	-15.36%	—	—
Max Drawdown (3Y) Largest decline over 3 years	-22.98%	—	—
Max Drawdown (5Y) Largest decline over 5 years	-46.32%	—	—
Max Drawdown (10Y) Largest decline over 10 years	-46.32%	—	—
Current Drawdown Current decline from peak	-23.82%	0.00%	-23.82%
Average Drawdown Average peak-to-trough decline	-13.50%	0.00%	-13.50%
Ulcer Index Depth and duration of drawdowns from previous peaks	5.08%	—	—

Volatility

Volatility by Period

	PSCH	CNCR	Difference
Volatility (1M) Calculated over the trailing 1-month period	4.90%	—	—
Volatility (6M) Calculated over the trailing 6-month period	14.54%	—	—
Volatility (1Y) Calculated over the trailing 1-year period	20.45%	0.00%	+20.45%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	22.94%	0.00%	+22.94%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	23.63%	0.00%	+23.63%

PSCH vs. CNCR - Expense Ratio Comparison

PSCH has a 0.29% expense ratio, which is lower than CNCR's 0.79% expense ratio.

Dividends

PSCH vs. CNCR - Dividend Comparison

PSCH's dividend yield for the trailing twelve months is around 0.01%, while CNCR has not paid dividends to shareholders.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016
CNCR Loncar Cancer Immunotherapy ETF	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
PSCH Invesco S&P SmallCap Health Care ETF	0.01%	0.04%	0.27%	0.01%	2.27%	0.00%	0.00%	0.00%	0.00%	0.00%	0.03%

Frequently Asked Questions

Which ETF is better, PSCH or CNCR?

On fees, PSCH is cheaper at 0.29% per year. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF is cheaper, PSCH or CNCR?

PSCH is cheaper with a 0.29% expense ratio, compared with 0.79% for CNCR.

Which ETF pays a higher dividend yield, PSCH or CNCR?

PSCH has the higher dividend yield at 0.01%, compared with 0.00% for CNCR.

What is the main difference between PSCH and CNCR?

PSCH tracks S&P SmallCap 600 Health Care Index, while CNCR tracks Loncar Cancer Immunotherapy Index. They also come from different issuers: Invesco and Exchange Traded Concepts. Their fees differ too: 0.29% for PSCH and 0.79% for CNCR.